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Molecular diagnosis of human papillomaviruses (HPVs) in cervicovaginal samples reveals a plethora of known and novel
HPV genomes. We describe the use of an overlapping PCR method to clone and analyze the complete genome of HPV 84
from cervicovaginal cells obtained from a 21-year-old Caucasian female with a normal Pap smear. The 7948-bp complete
nucleotide sequence of HPV 84 was determined from five overlapping PCR products by sequence walking. A BLAST
homology search demonstrated that HPV 84 was most closely related to HPV 61 (89%), HPV 72 (86%), and HPV 83 (85%) by
nucleotide sequence analysis of the L1 open reading frame, placing it in the HPV genome homology group A3. Previously,
this virus had been identified as Pap155. Based on extensive epidemiological data, HPV 84 is a highly prevalent genital
papillomavirus primarily detected in normal and HIV-infected women. © 2001 Academic Press
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DNA viruses with circular double-stranded DNA ge-
nomes about 8 kb in size. These viruses infect humans
as well as numerous and diverse animal species. Hu-
man papillomaviruses (HPVs) are classified into more
than 100 types to date, including 84 that have been
cloned and characterized, whereas others have been
identified by partial sequence analysis of a polymerase
chain reaction (PCR) product. For a papillomavirus to be
recognized as a distinct type, the full genome should be
cloned and the sequence of the L1 gene should be no
more than 90% similar to previously typed HPVs (Delius
et al., 1998). Most genital benign and malignant neoplas-
tic lesions are associated with HPV infections. HPVs are
categorized into mucosal and cutaneous types, as well
as epidermodysplasia verruciformis (EV)-associated
types. In addition, HPV types are also categorized into
low- and high-risk types in accordance with their asso-
ciation with malignant lesions (Bosch et al., 1995; Van
Ranst et al., 1996).
We have characterized a novel genital HPV type, now
called HPV 84, that was amplified and cloned from the
cervicovaginal cells obtained from a 21-year-old Cauca-
sian female with a normal cervical cytologic analysis by
use of an overlapping PCR method. An overlapping PCR
method has been reported as a useful tool for obtaining
HPV DNA from specimens with low copy numbers
(Forslund and Hansson, 1996). The genome of HPV 841 To whom correspondence and reprint requests should be ad-
ressed. Fax: (718) 430-8975. E-mail: burk@aecom.yu.edu.
109contains the 452-bp MY09/MY11 DNA fragment previ-
ously known as either MM8 or Pap155 (Manos et al.,
1994). This partial genome was originally characterized
from a vulvar sample from a patient with genital warts
and cervical abnormalities (Manos et al., 1994).
In this communication, we report the cloning of Pap155
using an overlapping PCR amplification method and the
determination of the complete nucleotide sequence. In
addition, phylogenetic analysis has been conducted and
the structure of the predicted HPV 84 proteins has been
determined.
RESULTS AND DISCUSSION
Complete nucleotide sequence and predicted open
reading frames
The PCR primers specific for the HPV 84 sequence are
shown in Table 1 and the organization of the five over-
lapping PCR products is shown in Fig. 1. The assembled
sequence of the viral genome revealed a total size of
7948 bp with a G1C content of 46.44%. The complete
nucleotide sequence is shown in Fig. 2. The sequence is
available in GenBank under Accession No. AF293960.
The DNA clones and sequence were submitted to the
Human Papillomavirus Reference Laboratory (Heidel-
berg), and the virus was assigned the number HPV 84. A
basic local alignment sequence tool (BLAST) homology
search using nucleotide sequence of the L1 open read-
ing frame (ORF) showed that HPV 84 is most closely
related to HPV 61 (89% homology), HPV 72 (86% homol-
ogy), and HPV 83 (85% homology), thus, satisfying the
criteria for a new HPV type (Delius et al., 1998). This
0042-6822/01 $35.00
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110 TERAI AND BURKrelationship places HPV 84 in the papillomavirus ho-
mology group A3 based on the Human Papillomavi-
ruses 1997 Compendium (http://www.stdgen.lanl.gov/
stdgen/virus/hpv/compendium/htdocs/COMPENDIUM_
PDF/97PDF/1/Intro97.pdf). HPV 84 represents the previ-
ously partially characterized HPV known as either MM8 or
Pap155 based on the 452-bp DNA fragment amplified by
the MY09/MY11 consensus PCR primers (Manos et al.,
1994). This partial genome was not detected with the GP5/
GP6 set of primers or with any of the JC9813-specific prim-
ers (Feoli-Fonseca et al., 1998).
Examination of the HPV 84 sequence for potential
genes showed the typical complement of papillomavirus
ORFs. The predicted ORFs are summarized in Table 2A.
Table 2B shows the homology of putative HPV 84 pro-
teins to the analogous proteins of several closely related
T
Primers Used to Clone Over
Plasmid No.a Insert size (kb)
1 0.7
2 4.5
3 1.0
4 1.8
5 0.6
a See Fig. 1.
FIG. 1. Organization of the five cloned overlapping PCR products and
location of predicted ORFs. (See Table 1 for sequence of primers and
Table 2A for exact location of ORFs.)HPV types. HPV 84 proteins were closely related to HPV
61, HPV 72, and HPV 83 proteins. Interestingly, the E6, E2,
and E4 ORFs were most closely related to those of HPV
61, whereas the E7, E1, L2, and L1 ORFs were closest to
HPV 83. The presence of an E5 protein situated between
the end of the E2 ORF and the start of the L2 ORF, which
is found in some but not all HPVs, was sought by com-
parison of this region in HPV 84 to the complete papil-
lomavirus database. None of the small ORFs in this
region of HPV 84 showed significant homology with
known E5 proteins.
Phylogenetic analysis
To investigate the relationship between HPV 84 and
related HPV genomes, nucleotide and amino acid se-
quences of the ORFs in HPV 84 were aligned with the
corresponding sequences of HPVs from group A3. Se-
quences were aligned using Sequencer software and
verified manually. Since not all related HPV genomes
were completely sequenced, a set of trees was con-
structed based on the sequence of the HPV L1 region
amplified by MY09/MY11. A representative tree is shown
in Fig. 3. The tree demonstrated that HPV 84 was most
closely related to L1AE6 (Ho et al., 1998c), also known as
CP6108 (Peyton and Wheeler, 1994), and other members
of the A3 clade.
The LCR
The sequence between the end of the L1 ORF and the
beginning of the E6 ORF is called the long control region
(LCR), also known as the upstream regulatory region
(URR) or noncoding region (NCR). This region contains
many of the cis-acting regulatory sequences that control
viral transcription and replication. The LCRs of related
HPV types, HPV 61, HPV 72, HPV 83, and HPV 16, are 776,
755, 851, and 814 bp long, respectively. The LCR of HPV
84 is 772 bp long. One of the elements present in pap-
DNA Fragments of HPV 84
Primer sequence (primer name; primer direction)
CCC CGA GGA AAC AAT TA-39 (5300F; forward)
GAT ATA CCT TGC CGT CA-39 (SP84R; reverse)
CAG GAT TAC CAC TTG CA-39 (500Fout; forward)
ACG TGC AGT TAA CGC CG-39 (5300Rout; reverse)
TAG GTC TAC TGT TTC CT-39 (MY98F; forward)
AGC ACT TCC CTG TCC ACT GTC C-39 (500R; reverse)
TGT GCC CTA TTC TTT TTC A-39 (MY84; forward)
AAA CAG TAG ACC TAC CCA G-39 (MY89; reverse)
GTG TCT GTT TGT TTG GTG-39 (Pap155-A; forward)
ATG CAC TTA AGG GAA AG-39 (Pap155-B; reverse)ABLE 1
lapping
59-TGA
59-GCA
59-AAA
59-CCT
59-GGG
59-TGC
59-ACG
59-AGG
59-TAT
59-ACTillomavirus LCRs is the origin of DNA replication (ORI).
The ORI typically contains an E1 binding site between
FIG. 2. Complete nucleotide sequence of HPV 84.
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112 TERAI AND BURKthe putative binding sites for two E2 binding sites
(ACCN6GGT) (Lu et al., 1993; Sun et al., 1996).
The HPV 84 LCR contains three E2 binding sites (see
Fig. 4). Two sites at 7500 and 7896 contain E1 binding
sites at positions 7841 and 7860. This region probably
represents the HPV 84 origin of DNA replication. Papil-
lomavirus LCRs also contain multiple binding sites for
transcriptional regulatory factors such as AP-1 (Chan et
l., 1990), NF-1 (Apt et al., 1993), SP-1 (Gloss and Bernard,
990), transcriptional enhancer factor (TEF)-1 (Ishiji et al.,
992), and YY-1 (Dong et al., 1994; May et al., 1994),
mong others. The organization of the HPV 84 LCR is
onsistent with that of other genital papillomaviruses.
egulatory sites include a TATA box representing the
6/E7 promoter at positions 7915 and 7921, just one base
pstream from the start of the E6 ORF at position 7922.
he predicted locations of these sites within the LCR of
PV 84-related HPV types, HPV 61, HPV 72, and HPV 83,
nd HPV 16 LCR are shown in Fig. 4. Based on the LCR
ength and position of multiple binding sites, the region
f HPV 84 is more similar to the low-risk HPV types.
iversity of HPV 84
To better understand the evolution and generation of
ndependent HPV types, we have compared the amino
cid and nucleotide differences of HPV 84 and those of
PV 61, the most closely related HPV type, as shown in
able 3. Both the nucleotide sequence and the amino
cid sequence of the L1 ORF are the most highly con-
erved. In contrast, the E7 and E2 ORFs have highly
onserved nucleotide sequences, but more divergent
TA
Location of Predicted ORF
ORF Start position First ATG Stop codon
E6 7922 1 447
E7 417 423 713
E1 694 715 2667
E2 2576 2609 3742
E4 3192 3198 3509
L2 4251 4263 5687
L1 5434 5665 7176
TABLE 2B
Homology of HPV 84 Amino Acid Sequences with Related HPVs
HPV 84 E6 E7 E1 E2 E4 L2 L1
HPV 61 65.3 (%) 56.3 71.6 59.9 63.7 69.8 79.6
HPV 72 63.3 52.5 72.2 59.7 62.1 70.3 79.6
HPV 83 60.1 59.8 73.0 57.1 53.8 73.0 80.0mino acid sequences. Most of the nucleotide substitu-
ions within each ORF were found in the third position
42.2 to 60.3%). Approximately 37 to 52% of all codons
nalyzed had a nucleotide change in the third position.
he conservation of DNA sequence and the lack of a
ontinuum between HPV 84 and HPV 61, the most closely
elated type, indicate that HPV 84 and HPV 61 have
merged as independent entities, equivalent to “species”
Bernard, 1994; Van Ranst et al., 1992). The distribution of
ucleotide changes in first, second, and third positions
uggests a gradual mode of molecular evolution of HPV
4 and HPV 61.
HPV 84 is of significant interest because it is one of
he most common types found in the genital tract of
omen with normal cytology. For instance, HPV 84 was
ound in 7.0% of HPV-infected college women (Burk et al.,
1996; Ho et al., 1998c). HPV 84 has also been detected in
ultiple HPV-type infections associated with condylo-
ata acuminata occurring in immunosuppressed pa-
ients (Brown et al., 1999). However, HPV 84 is uncom-
on in patients with dysplasia and cancer (Ho et al.,
998a,b; Meyer et al., 1998). One large study demon-
trated that the proportion of women with HPV 84 was
FIG. 3. Phylogenetic tree based on sequences of the HPV L1 region
A
Size of Putative Proteins
ength of protein-
ing sequence (bp) Amino acids
Predicted molecular
mass of protein
(kDa)
444 148 17.4
288 96 10.5
1950 650 72.8
1131 377 43.0
309 103 11.2
1422 474 50.6
1509 503 56.4BLE 2
s and
L
codbetween the MY09/MY11 primers. Sequences were aligned and a tree
was generated using the CLUSTAL program.
2 bindi
t box); E2
113HUMAN PAPILLOMAVIRUS 84higher in women with human immunodeficiency virus
(HIV)-1 infection (4.4%) than in HIV-negative women
(0.2%) and its prevalence increased inversely with the
CD4 count in HIV-infected patients (Palefsky et al., 1999).
In addition, HPV 84 tends to occur as a multiple-type
infection involving HPV 16 (Franco et al., 1999). Thus,
HPV 84 is a relatively prevalent genital tract papilloma-
virus in a variety of patient populations, including pa-
tients with HIV infection.
FIG. 4. Comparison HPV 84 LCR with related HPV types (HPV 61, HPV
sites (AP-1, NF-1, SP-1, TEF-1, YY-1, poly(A) signal, TATA box, and E1 and E
ranscriptional enhancer factor-1 (gray box); E1, E1 binding domain (gray
T
Divergence between HPV 84 E6, E7, E1, E2, E4, E5, L2,
Comparison
Codons
compareda
Similarity (%) with
compared codonsa
Amino acid Nuc
E6 144 65.3 6
E7 95 56.8 6
E1 645 72.4 7
E2 374 60.7 7
E4 97 67.0 7
L2 457 71.8 6
L1 501 80.0 7a Not counting gaps and terminal extensions.
b Including silent codons.MATERIALS AND METHODS
Overlapping PCR
The HPV 84 genome was amplified by PCR as over-
lapping fragments that were cloned into a plasmid vec-
tor. Initial PCR primers were designed by alignment of
closely related HPV genomes determined by phyloge-
netic analysis using the sequences of the 452-bp L1
region amplified by the MY09/MY11 consensus PCR
HPV 83) and HPV 16 LCR. LCR length and position of multiple binding
ng domains) are shown, as indicated. TATA, TATA box (black box); TEF-1,
, E2 binding domain (gray box); Poly(A), poly(A) signal (gray box).
Genes from Most Closely Related HPV Type (HPV 61)
Nucleotide substitutions by
codon positionb (%) (total: 100%) Codons with a
third position
changeb (%)1st 2nd 3rd
32.6 15.2 52.2 50.0
28.4 22.7 48.9 45.3
26.7 17.9 55.4 44.0
35.6 22.2 42.2 37.2
28.2 21.2 50.6 44.3
28.1 14.4 57.6 52.5
24.8 14.9 60.3 43.772, andABLE 3
and L1
leotide
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114 TERAI AND BURKprimers (Chan et al., 1995; Manos et al., 1994). A clinical
sample previously identified to contain a high copy num-
ber of Pap155 was used (Burk et al., 1996; Ho et al.,
998c). The Pap155-positive sample DNA was subjected
o PCR amplifications using either Gold Taq DNA poly-
erase (Perkin–Elmer Applied Biosystems, Foster City,
A) or an equal mixture of Gold Taq (Perkin–Elmer) and
wo DNA polymerase (Platinum Taq DNA Polymerase
igh Fidelity, Gibco BRL, Rockville, MD). Pwo polymer-
se has an inherent 39–59 exonuclease proofreading
ctivity. The PCR products were separated by electro-
horesis in agarose gels, stained with ethidium bromide,
nd visualized under an ultraviolet transilluminator. After
onfirmation of appropriate product size, each PCR prod-
ct was purified (Qiagen Gel Extraction Kit, Qiagen, Va-
encia, CA) and ligated into the p-GEM-T Easy vector
Promega, Madison, WI) according to the manufacturer’s
nstructions.
equencing strategy
To determine the nucleotide sequence, each DNA
nsert was sequenced using SP6 and T7 primers flanking
he HPV insert. Additional primers were designed by
alking through the insert using the most recent se-
uence (Delius and Hofmann, 1994). Sequencing was
one on an ABI Prism Model 377 automated sequencer
Perkin–Elmer Applied Biosystems) in the Einstein core
acility. The overlapping sequence fragments were as-
embled manually and confirmed by sequencing the
omplementary strand. Several additional primers were
sed to clarify sequence ambiguities. Once assembled,
he sequence was analyzed for homology to other HPVs
sing BLAST software (Altschul et al., 1997). The same
oftware was used to determine protein sequence ho-
ologies.
hylogenetic analysis
Phylogenetic trees for all published sequences are
vailable from the Human Papillomaviruses 1997 Com-
endium on Line (http://www.stdgen.lanl.gov/stdgen/
irus/hpv/compendium/htdocs/COMPENDIUM_PDF/
7PDF/1/Intro97.pdf). Phylogenetic trees were calculated
rom individual ORFs, putative proteins, and LCRs, to
etermine the association of HPV 84 with the available
PV sequences available through the HPV database
sing public domain software (Higgins and Sharp, 1988).
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